Al-Nemrawi N, Hameedat F, Al-Husein B, Nimrawi S
In published preclinical research, BPC-157 has been administered at doses ranging from 6 to 50 micrograms per kilogram body weight in animal models, with most tissue-repair and gastric-protection protocols using 10 to 20 mcg/kg once or twice daily (PMID 21030672, PMID 32558293, PMID 38980576)
Following oral administration, the drug must be absorbed across the walls of the GI tract and then must escape metabolism as it passes through the liver, in order to reach the systemic circulation
In a mouse model study, PQQ supplementation reduced pro-inflammatory cytokine expression, particularly NLRP3, NOS-2, and IL-6
These properties make BPC-157 a particularly active subject of study in the fields of regenerative medicine and experimental gastroenterology
Individual factors like age, hair type, and the underlying cause of loss guide customization